The present invention relates to modified Fc-containing molecules including modified antibodies characterized by increased resistance to host and pathogen-derived proteases, ability to interact with Fc&gammaR receptors except with Fc&gammaRI, and lack of induction of IL-10 secretion by macrophages, and methods of using and making them.